KRMD KORU Medical: Company Value to Revenue

Official company branding of KORU Medical Systems Inc. (KRMD)

KORU Medical Systems dominates the home subcutaneous drug delivery systems segment via its Freedom platform. The enterprise value-to-revenue dynamics demonstrate market expectations, where 3141.34 reflects the latest metric value. Growth is supported by the relevance of devices for immunodeficiency therapy, while sustainable margins are ensured through diversified consumables logistics and reliable supply channels.

KORU Medical Systems, Inc. (KRMD): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

KRMD (KORU Medical Systems, Inc.): analytical breakdowns and indicator data

- current quotes and average value forecast:
Initial company analysis:KRMD - KORU Medical Systems Inc.
Manufactured products of KORU Medical

This indicator determines the market value of the business, accounting for net debt relative to sales volume. By analyzing the EV-to-revenue ratio, an investor assesses the company's scaling efficiency. For KORU Medical Systems (KRMD), this metric reflects the capitalization of high-tech facilities in New York. Production automation and strict polymer control establish a foundation for stable growth. A high value for this indicator confirms the asset's reliability when attracting investment.

Competitor analysis

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|ICUI: EV/Sales Multiple|Company Value to Revenue Ratio XRAY|LMAT (LeMaitre Corp) - EV/Sales Multiple|ATRC (AtriCure Inc) - Enterprise Value-to-Revenue Coefficient|EV/Sales Multiple STAA|NAGE (ChromaDex Corp) - Business Value to Revenue|ZimVie Inc. - Company Value to Revenue|Total Company Value-to-Revenue Ratio angiodynamics.com (ANGO)|CERS - Enterprise Value-to-Revenue Ratio|TKNO - EV/Sales Multiple|Monogram Technologies Inc (MGRM) - Enterprise Value-to-Revenue Ratio|STSS - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio InfuSystem Holdings, Inc.|Enterprise Value-to-Revenue Multiple Utah Medical Products UTMD|Enterprise Value-to-Revenue Ratio Nyxoah SA (NYXH)|Enterprise Value-to-Revenue Coefficient MBOT|EV/Sales Multiple PDEX (Pro-Dex Inc.)|Enterprise Value-to-Revenue Coefficient ZTEK (Zentek Limited)|elutia.com - EV/Sales Multiple|Business Value to Revenue MLSS (milestonescientific.com)|NXGL (NEXGEL Inc.) - Company Value to Revenue|Retractable Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple